Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans

Drug Metabolism and Disposition

Volumn 25, Issue 9, 1997, Pages 1022-1031

  Chiba, Masato ^a   Xu, Xin ^b   Nishime, Joy A ^b   Balani, Suresh K ^b   Lin, Jiunn H ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MONTELUKAST; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

AEROBIC METABOLISM; ARTICLE; ASTHMA; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG OXIDATION; DRUG PROTEIN BINDING; DRUG SULFATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

ACETATES; ADULT; CHILD; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MICROSOMES, LIVER; MIDDLE AGED; MONOAMINE OXIDASE; QUINOLINES;

EID: 0030783057     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 4 receptor antagonist devoid of peroxisomal enzyme induction. Bioorg. Med. Chem. Lett. 5, 283-288 (1995).
2. 4 receptor antagonist. Can. J. Physiol. Pharmacol. 73, 191-201 (1995).
3. M. Chiba, M. Hensleigh, J. A. Nishime, S. K. Balani, and J. H. Lin: Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metab. Dispos. 24, 307-314 (1996).
4. C. Dufresne, M. Gallant, Y. Gareau, R. Ruel, L. Trimble, and M. Labelle: Synthesis of montelukast (MK-0476) metabolic oxidation products. J. Organic Chem. 61, 8518-8525 (1996).
5. M. Chiba, J. A. Nishime, and J. H. Lin: Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, and investigational human immune deficiency virus protease inhibitor. J. Pharmacol. Exp. Ther. 275, 1527-1534 (1995).
6. A. Dixit and T. E. Roche: Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diural conditions. Arch. Biochem. Biophys. 223, 50-63 (1984).
7. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4, 879-885 (1981).
8. J. B. Besunder, M. D. Reed, and J. L. Blumer: Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin. Pharmacokinet. 14, 189-216 (1988).
9. G. L. Kearns and M. D. Reed: Clinical pharmacokinetics in infants and children. A reappraisal. Clin. Pharmacokinet. 17, 29-67 (1989).
10. A. H. Neims, M. Warner, P. M. Loughnan, and J. V. Aranda: Developmental aspects of the hepatic cytochrome P450 monooxygenase system. Annu. Rev. Pharmacol. Toxicol. 16, 427-445 (1976).
11. G. J. Dutton: Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu. Rev. Pharmacol. 18, 17-35 (1978).
12. D. M. Ziegler: Microsomal flavin-containing monooxygenase: oxygenation of nucleophilic nitrogen and sulfur compounds. In "Enzyme Basis of Detoxication" (W. B. Jakoby, ed.), vol. 1, pp. 201-227. Academic Press, New York, 1980.
13. D. M. Ziegler: Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol. 33, 179-199 (1993).
14. H. Uehleke: N-hydroxylation. Xenobiotica 1, 327-338 (1971).
15. L. L. Poulsen, R. M. Hyslop, and D. M. Ziegler: S-oxygenation of N-substituted thioureas catalyzed by the pig liver microsomal FAD containing monooxygenase. Arch. Biochem. Biophys. 198, 78-88 (1979).
16. G. L. Kedderis and D. E. Rickert: Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism: role of flavin-containing monooxygenase. Drug Metab. Dispos. 13, 58-61 (1985).
17. M. E. McManus, I. Stupans, W. Burgess, J. A. Koening, P de la M. Hall, and D. J. Birkett: Flavin-containing monooxygenase activity in human liver microsomes. Drug Metab. Dispos. 15, 256-261 (1987).
18. A. Madan, A. Parkinson, and M. D. Faiman: Role of flavin-dependent monooxygenases and cytochrome P450 enzymes in the sulfoxidation of S-methyl N,N-diethylthiolcarbamate. Biochem. Pharmacol. 46, 2291-2297 (1993).
19. A. Madan and M. D. Faiman: NADPH-dependent. regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic. diethyldithiocarbamate methyl ester by rat liver microsomes. Drug Metab. Dispos. 22, 324-330 (1994).
20. B. L. Blake, R. L. Rose, R. B. Mailman, P. F. Levi, and E. Hodgson: Metabolism of thioridazine by microsomal monooxygenase: relative roles of P450 and flavin-containing monooxygenase. Xenobiotica 25, 377-393 (1995).
21. A. J. Newlands, D. A. Smith, B. C. Jones, and G. M. Hawksworth: Metabolism of non-steroidal anti-inflammatory drugs by cytochrome P450 2C. Br. J. Clin. Pharmacol. 34, 152P (1992).
22. D. A. Smith and B. C. Jones: Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem. Pharmacol. 44, 2089-2098 (1992).
23. A. Mancy, P. Broto, S. Dijols, P. M. Dansette, and D. Mansuy: The substrate binding site of human liver cytochrome P450 2C9: an ap proach using designated tienilic acid derivatives and molecular modeling. Biochemistry 34, 10365-10375 (1995).
24. R. Thibert, H. Mach, S. D. Clas, D. R. Meisner, and E. B. Vadas: Characterization of the self-association property of a leukotriene D4 receptor antagonist, montelukast. Int. J. Pharm. 134, 59-70 (1996).